No abstract available
MeSH terms
-
Antibodies, Monoclonal / adverse effects*
-
Antibodies, Monoclonal / therapeutic use
-
Antibodies, Monoclonal, Murine-Derived
-
Antigens, CD20 / immunology
-
Antineoplastic Agents / adverse effects*
-
Antineoplastic Agents / therapeutic use
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Drug Resistance, Neoplasm
-
Humans
-
Immunoglobulins, Intravenous / therapeutic use*
-
Lymphoma, Follicular / drug therapy*
-
Lymphoma, Follicular / immunology
-
Male
-
Middle Aged
-
Neutropenia / chemically induced*
-
Neutropenia / drug therapy*
-
Recurrence
-
Rituximab
-
Treatment Outcome
Substances
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Murine-Derived
-
Antigens, CD20
-
Antineoplastic Agents
-
Immunoglobulins, Intravenous
-
Rituximab